injectable glp-1 agonists Patients with Obesity Showed High Discontinuation, Low Reinitiation of RAs Top GLP-1 Agonists Balance Weight

[112] Immediate-release formulations have higher potential for abuse via insufflation (snorting) or intravenous injection due to a more favorable pharmacokinetic profile and easy crushability (especially tablets)

Enviamos atoda Espaa y Amrica

Its role in gut health extends beyond glucose regulation to include mucosal barrier maintenance and intestinal immune modulation

5.6.4 Endpoint selection and standardization Across the 12 RCTs, seven different primary endpoints were used (VAS, TCSS, NDS, VPT, NSS, SNAP, SNCV), and only two trials adopted composite scores recommended by the Toronto Consensus on Diabetic Neuropathy (Pop-Busui et al., 2017)